Christopher Boyer

Biography

 Mr Boyer specialises in the selling of biotechnology, the culmination of his 20+ year career spanning its discovery, development and commercialisation. Most recently, as Executive Director of Bio-Link, Mr Boyer led licensing efforts for a range of drug and diagnostic opportunities and brought several deals to fruition. Prior to joining Bio-Link, Mr Boyer served as Business Development Manager at Cryptome Pharmaceuticals, a Melbourne-based peptide therapeutics developer. Earlier he was Manager, Corporate and Strategic Development at San Diego-based drug developer NewBiotics, where he negotiated contracts and contributed to a major co-development deal in cancer chemotherapeutics. Mr Boyer also consulted to San Diego’s Halozyme Therapeutics, a developer of therapeutic enzymes, preparing project valuations in support of a successful capital raising. Mr Boyer draws upon deep technical insights acquired during his extensive R&D experience in small molecule drug discovery and molecular neuroscience, attained at Novartis and the Howard Hughes Medical Institute respectively. He earned a BS in Animal Physiology and Neuroscience from the University of California, San Diego, and augmented his business skills with an MBA in Marketing from the University of San Diego.

Research Interest

 Cancer